Covid endemic upgrade

The infection will most likely be with us for the next couple of years, in one type or another.

Zoe signs since today

Sore throat, 62%

Headache, 53%

Blocked nose, 53%

Runny nose, 53%

Cough, no phlegm 52%

Sneezing, 47%

Cough with phlegm, 45%

Hoarse, 43%

Muscle discomforts/ pains 28%

Fatigue, 22%

Dizzy, light headed, 21%

Altered odor, 20%

Swollen neck glands, 18%

Chest discomfort/ tightness, 16%

Sore eyes, 16%

Shortness of breath, 16%

Loss of odor, 16%

Earache, 15%

Joint/ shoulder discomfort, 11%

Chills or shivers, 10%

Prevalence

One in 24

Full report download
https://console.cloud.google.com/storage/browser/covid-public-data; tab= objects?pli= 1 & prefix= & forceOnObjectsSortingFiltering= incorrect

ONS information
https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/articles/coronaviruscovid19 latestinsights/infections

3.21% in England (1 in 30 individuals)

2.83% in Wales (1 in 35 individuals)

2.92% in Northern Ireland (1 in 35 individuals)

3.02% in Scotland (1 in 35 individuals)

Self-reported long COVID

2.3 million individuals (3.5% of population)

80% signs a minimum of 12 weeks

46% a minimum of one

22% a minimum of 2 years

Fatigue, problem focusing, shortness of breath, muscle pains

Affected the everyday activities, 1.6 million individuals, (72%)

Hospital admissions, more ‘with’ than ‘for’

CCU, more ‘with’ than ‘for’

Excess deaths

Deaths signed up, week ending 14 October 2022 was 13,253,

which was 14.9% above the five-year average

(1,719 excess deaths).

Deaths including COVID-19 represented 4.7% of all UK deaths

UK main information

https://covid19globalcases.com/covid-endemic-upgrade/